Brain News and Research

RSS

The human brain is the center of the human nervous system and is a highly complex organ. Enclosed in the cranium, it has the same general structure as the brains of other mammals, but is over three times as large as the brain of a typical mammal with an equivalent body size.

‘Virtual language therapist’ set to benefit aphasia patients

Portuguese researchers have developed an online speech recognition tool for the treatment of word naming difficulties in patients with aphasia.

26 Oct 2012

Cardiac arrhythmias: latest developments in diagnosis and treatment

A new Lancet Series explores the latest developments in the diagnosis, treatment and biology of cardiac arrhythmias, ahead of the American Heart Association’s annual meeting taking place this year on Nov 3–7 in Los Angeles, CA, USA.

26 Oct 2012

Researchers identify genes that control regeneration of the intestine in planarian flatworms

Researchers report in the journal Developmental Cell that they have identified genes that control growth and regeneration of the intestine in the freshwater planarian Schmidtea mediterranea.

26 Oct 2012

Human Gene Therapy articles describe two novel anti-tumor therapies

Targeted T-cells can seek out and destroy tumor cells that carry specific antigen markers. Two novel anti-tumor therapies that take advantage of this T-cell response are described in articles published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

26 Oct 2012

Sleep deprivation affects memory formation in bees

Everyone feels refreshed after a good night's sleep, but sleep does more than just rejuvenate, it can also consolidate memories. 'The rapid eye movement form of sleep and slow wave sleep are involved in cognitive forms of memory such as learning motor skills and consciously accessible memory', explains Randolf Menzel from the Freie Universt-t Berlin, Germany.

26 Oct 2012

NewYork-Presbyterian/Columbia participates in Symplicity system trial for hypertension

Patients with hypertension whose blood pressure cannot be brought down to safe levels despite taking three or more medications may have some relief coming their way. An innovative, first-of-its-kind clinical trial for a device representing a dramatic shift in treatment approaches for the toughest-to-treat patients is currently being conducted at NewYork-Presbyterian Hospital.

From Medtronic 26 Oct 2012

Highlights from 25th European College of Neuropsychopharmacology Congress

In the course of the 25th ECNP Congress leading experts and five and a half thousand psychiatrists, neurologists, neuroscience researchers and public health professionals from over 90 different countries met from 13 to 17 October 2012 in Vienna, Austria, to celebrate ECNP´s 25-year anniversary and engage in groundbreaking debate.

26 Oct 2012

PFO closure with investigational device may prevent cryptogenic ischemic stroke

A clinical trial indicates that using an investigational medical device to close a PFO, or "hole in the heart," may be superior to medical management alone in the prevention of a repeated stroke.

26 Oct 2012

UWCCC enrolls first patient in Phase 1-2 PET imaging trial of LIGHT for solid tumors

Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that the University of Wisconsin Carbone Cancer Center, a leading oncology research institution, has enrolled the first patient in a Phase 1-2 positron emission tomography (PET) imaging trial of I-124-CLR1404, a cancer-targeted PET imaging agent, in patients with nine solid tumor types, including triple negative breast, soft tissue sarcoma, colorectal, gastric, esophageal, prostate, ovarian, pancreatic and head & neck cancer.

26 Oct 2012

Omega-3 fatty acid can enhance cognition in highly functional young individuals

While Omega-3 essential fatty acids-found in foods like wild fish and grass-fed livestock-are necessary for human body functioning, their effects on the working memory of healthy young adults have not been studied until now.

26 Oct 2012

Researchers discover genetic biomarker for age-related hearing loss

University of South Florida researchers have identified a genetic biomarker for age-related hearing loss, a major breakthrough in understanding and preventing a condition of aging that affects 30 million Americans and greatly diminishes their quality of life.

26 Oct 2012

Sevoflurane, propofol produce different metabolic patterns in brains of unconscious children

Two commonly used anesthetics produce different metabolic patterns in the brains of unconscious children, according to a study from the November issue of a Anesthesiology.

26 Oct 2012

Boston Scientific S-ICD system now available in Northwestern's Bluhm Cardiovascular Institute

Sudden cardiac arrest (SCA) is a condition in which the heart suddenly stops pumping blood. When this occurs, blood stops flowing to the brain and other major organs. Recent estimates show that approximately 850,000 people in the United States are at risk of SCA, and most of the people who have SCA, die from it. But, rapid treatment of SCA by using an implantable defibrillator can be lifesaving.

26 Oct 2012

Stroke survivors who smoke risk their life

In a study detailed in the American Heart Association’s journal Stroke, researchers recruited 1,589 stroke survivors between 1996 and 1999 and examined the occurrence of deaths, recurrent strokes and heart attacks over a 10-year period. They found smokers and former smokers who suffered stroke had greater risk of death, multiple strokes or heart attack when compared to patients who were never smokers.

25 Oct 2012

AHA/ASA honors UCLA Medical Center with Get With The Guidelines-Stroke award

Ronald Reagan UCLA Medical Center has received the American Heart Association/American Stroke Association's Get With The Guidelines-Stroke Gold Plus Quality Achievement Award.

25 Oct 2012

Simple video game can help children with serious anger problems

Children with serious anger problems can be helped by a simple video game that hones their ability to regulate their emotions, finds a pilot study at Boston Children's Hospital. Results were published online October 24 in the journal Adolescent Psychiatry.

25 Oct 2012

Study indicates that Firemaster 550 is an endocrine disruptor

The flame-retardant mixture known as "Firemaster 550" is an endocrine disruptor that causes extreme weight gain, early onset of puberty and cardiovascular health effects in lab animals, according to a new study spearheaded by researchers from North Carolina State University and Duke University.

25 Oct 2012